Relation between age and gender differences in plasma triglyceride concentrations and coronary artery disease in Southern Turkey

Clinica Chimica Acta

Volumn 339, Issue 1-2, 2004, Pages 123-128

  Acartürk, Esmeray ^a   Çayli, Murat ^a   Akpinar, Onur ^a   Attila, Gülen ^a   Demir, Mesut ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

Author keywords

Coronary artery disease; Triglycerides; Women

Indexed keywords

BIOLOGICAL MARKER; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DIABETES MELLITUS; DISEASE MARKER; FAMILY HISTORY; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; POPULATION SIZE; PRIORITY JOURNAL; SEX DIFFERENCE; SEX RATIO; TRIACYLGLYCEROL BLOOD LEVEL; TURKEY (REPUBLIC);

EID: 0345734385     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2003.10.001     Document Type: Article

References (23)

1. Onat A., Keleş I., Çetinkaya A.et al. Prevalence of all-cause and coronary mortality in Turkish adults as assessed by 10-year follow data of the Turkish Adult Risk Factor Study. Arch. Turk. Soc. Cardiol. 29:2001;8-19.
2. Sans S., Kesteloot H., Kromhout D. The burden of cardiovascular disease mortality in Europe. Task force of the European society of cardiology on cardiovascular mortality and morbidity statistics in Europe. Eur. Heart J. 18:1997;1231-1248.
3. Gotto A.M. Jr. Triglyceride: The forgotten risk factor. Circulation. 97:1998;1027-1028.
4. D'Agostino R.B., Russel M.W., Huse D.M., Ellison R.C., Silbershatz H., Wilson P.W.et al. Primary and subsequent coronary risk appraisal: new results from the Framingham Study. Am. Heart J. 139:2000;272-281.
5. Sposito A.C., Mansur A.P., Maranhao R.C., Martinez T.R.L., Aldrighi J.M., Ramires J.A.T. Triglyceride and lipoprotein (a) are markers of coronary artery disease severity among postmenopausal women. Maturitas. 39:2001;203-208.
6. Sharrett A.R., Ballantyne C.M., Coady S.A., Heiss G., Sorlie P.D., Catellier D.et al. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions. The Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 104:2001;1108-1113.
7. Hokanson J.E., Austin M.A. Plasma triglyceride levels is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol levels: a meta-analysis of population-based prospective studies. J. Cardiovasc. Risk. 3:1996;213-219.
8. World Health Organization International Society of Hypertension Guidelines for the Management of Hypertension. J. Hypertens. 17:1999;151-183.
9. American Diabetes Association The Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 22(Suppl. 1):1999;5-19.
10. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation and treatment of high cholesterol in adults (adult treatment panel III). JAMA. 285:2001;2486-2497.
11. The CASS principal investigators and their associates Myocardial infarction and mortality in the Coronary Artery Surgery Study (CASS) randomised trial. N. Engl. J. Med. 310:1984;750-758.
12. Castelli W.P. Epidemiology of triglycerides: a view from Framingham. Am. J. Cardiol. 70:1992;3H-9H.
13. Nielsen N.E., Olsson A.G., Swahn E. Plasma lipoprotein particle concentrations in postmenopausal women with unstable coronary artery disease. Analysis of diagnostic accuracy using receiver operating characteristics. J. Intern. Med. 247:2000;43-52.
14. Jeppesen J., Hein H.O., Suadicani P., Gyntelberg F. Triglyceride concentration and ischemic heart disease. An eight year follow-up in the Copenhagen Male Study. Circulation. 97:1998;1029-1036.
15. Kannel W.B., Castelli W.P., Gordon T., McNamara P.M. Serum cholesterol, lipoproteins and the risk of coronary heart disease. The Framingham Study. Ann. Intern. Med. 74:1971;1-12.
16. Miller M., Seidle A., Moalemi A., Pearson T.A. Normal triglyceride levels and coronary artery disease events: the Baltimore Coronary Observational Long-Term Study. J. Am. Coll. Cardiol. 31:1998;1252-1257.
17. Sacks F.M., Pfeffer M.A., Moye L.A., Rouleau J.L., Rutherford J.D., Cole T.G.et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N. Engl. J. Med. 335:1996;1001-1009.
18. Assmann G., Schulte H., von Eckardstein A. Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men. Am. J. Cardiol. 77:1996;1179-1184.
19. Onat A. Risk factors and cardiovascular disease in Turkey. Atherosclerosis. 56:2001;1-10.
20. Halkes C.J.M., Castro Cabezas M., van Wijk J.P.H., Erkelens D.W. Obesity overrules the beneficial gender effects on triglyceride metabolism in non-obese subjects. Atherosclerosis. 151:2000;S97. [Abstract].
21. van Beek A.P., de Ruijter-Heijstek F.C., Erkelens D.W., de Bruin T.W. Menopause is associated with reduced protection from postprandial lipemia. Atheroscler. Thromb. Vasc. Biol. 19:1999;2737-2741.
22. Reardon M.F., Nestel P.J., Craig I.H., Harper R.W. Lipoprotein predictors of the severity of coronary artery disease in men and women. Circulation. 71:1985;881-888.
23. Gaziano J.M., Hennekens C.H., O'Donnell C.J., Breslow J.L., Buring J.E. Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Circulation. 96:1997;2520-2525.